This news is delayed by 15 minutes, sign up now to get live news & full features.
SNPX SYNAPTOGENIX INC
+ add to watchlist
$23.24
synaptogenix is a clinical-stage biopharmaceutical company that has historically worked to develop novel therapies for neurodegenerative diseases.
Mkt Cap: $5.7M
52 Week High: $25.55
P/E: 0.00
52 Week Low: $1.84
Dividend: $0.00
Shares Outstanding: 1.39M